Castle Biosciences, Inc.
CSTL
$25.62
-$0.29-1.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.16% | 4.21% | 0.28% | -6.13% | 4.77% |
| Total Receivables | -12.23% | -4.93% | -6.39% | 9.91% | 3.10% |
| Inventory | 18.54% | 3.39% | 22.15% | -15.81% | 23.78% |
| Prepaid Expenses | -35.90% | -3.31% | 6.00% | 47.57% | -13.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 0.99% | 2.55% | -0.21% | -2.99% | 4.46% |
|
|
|||||
| Total Current Assets | 0.99% | 2.55% | -0.21% | -2.99% | 4.46% |
| Net Property, Plant & Equipment | 12.20% | 11.69% | 34.51% | 6.19% | 11.40% |
| Long-term Investments | 0.01% | -0.01% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.01% | -0.01% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -2.50% | -2.43% | 39.01% | -29.65% | -4.35% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 69.48% | 40.41% | 4.72% | 5.59% | -26.93% |
| Total Assets | 2.80% | 3.31% | 8.57% | -5.56% | 3.24% |
|
|
|||||
| Total Accounts Payable | 53.23% | -7.36% | 55.03% | 23.20% | 1.34% |
| Total Accrued Expenses | 19.29% | 21.43% | 30.95% | -38.57% | 10.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.26% | -58.78% | 38.06% | 24.56% | 17.13% |
| Total Finance Division Other Current Liabilities | -21.33% | 25.54% | 24.88% | 40.19% | 173.28% |
| Total Other Current Liabilities | -21.33% | 25.54% | 24.88% | 40.19% | 173.28% |
| Total Current Liabilities | 24.17% | 8.68% | 36.53% | -24.53% | 11.51% |
|
|
|||||
| Total Current Liabilities | 24.17% | 8.68% | 36.53% | -24.53% | 11.51% |
| Long-Term Debt | -4.07% | 24.12% | -9.25% | -8.46% | -2.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.43% | -0.39% | 79.04% | -1.90% | -2.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.13% | 2.51% | 452.69% | -47.92% | -61.92% |
| Total Liabilities | 12.47% | 7.15% | 45.50% | -18.56% | 2.57% |
|
|
|||||
| Common Stock & APIC | 0.89% | 1.77% | 1.60% | 1.59% | 0.84% |
| Retained Earnings | -1.05% | -0.23% | 2.00% | -12.92% | 4.57% |
| Treasury Stock & Other | 11.25% | 515.38% | -70.23% | -43.04% | -51.37% |
| Total Common Equity | 0.82% | 2.56% | 3.42% | -3.41% | 3.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.82% | 2.56% | 3.42% | -3.41% | 3.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.82% | 2.56% | 3.42% | -3.41% | 3.35% |
|
|
|||||